← Back to headlines
Bristol-Myers Squibb Stock at Risk From Proposed Medicare Drug Price Negotiation Updates
Bristol-Myers Squibb Company (BMY) stock faces potential risks due to proposed updates concerning Medicare drug price negotiations.
30 Jun, 13:07 — 30 Jun, 13:07
Sources
Showing 1 of 1 sources
